Kiri Industries (KIRIINDUS)

FairStock Score: 15/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Debt/equity ratio of 0.37 suggests a moderately leveraged balance sheet.
• Promoter holding of 36.72% provides some owner alignment.
• Reported quarterly net profit of ₹5,023 Cr could be a material non-operating cash infusion if realized.
• ROCE of 10.52% is positive, though modest, indicating the core assets are not loss-making.
• Share price is well below its 52-week high of ₹779.00, reducing sentiment risk.

Concerns

• P/E is 0.00 and profit growth is -107.76%, meaning there are no credible recurring earnings.
• Price-to-book of 6.41 against a book value of only ₹63.77 leaves no margin of safety.
• Latest quarter's ₹5,023 Cr profit on ₹174 Cr sales is clearly exceptional/non-operating and not reflective of the business.
• Piotroski F-Score of 3/9 indicates poor fundamental health; zero dividend yield also returns nothing to investors.

AI Analysis

Let me start with what I am not buying: ₹5,023 crore of quarterly profit on ₹174 crore of sales. In chemistry, that is not operating profit; in investing, it is not a reason to pay ₹408.60 for a share whose book value is only ₹63.77. The P/E of 0.00 and profit growth of -107.76% tell me there are no real recurring earnings to put a multiple on. I look for durable franchises, but Kiri's sales have shrunk 2.82%, ROCE is just 10.52%, and the Piotroski score is 3 out of 9. Those are signs of a follower, not a leader. The balance sheet is not reckless—debt/equity is 0.37—and promoter holding of 36.72% gives some alignment. Still, at 6.41 times book, the market is treating a cyclical dyes maker as if it has quality compounding. The huge reported profit may be exceptional income, perhaps legal or arbitration related; if real cash materializes, it could change the story. But until it appears in book value, debt reduction, or dividends, I treat it as a lottery ticket. My mentor taught me to buy at a margin of safety, not at a multiple of peak hope. This stock offers poor underlying fundamentals, no dividend, and a valuation that assumes good news. It belongs on a watchlist, not in a portfolio. I would need to see the core dyes business grow, the abnormal profit turn into tangible assets, and an ROE that comes from operations, not arithmetic.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer